Drug Delivery

The pharmaceutical company has forged a partnership with the nanotechnology specialist to use nanoparticle tech and formulation to advance its products.

The digital therapeutics specialist has announced the last patient has ended participation in a study investigating a precision solution for hypertension.

Novartis has recently set up a new contract development and manufacturing unit called Global Biotech Co-operations (GBTC).

The companyâs Precision Olfactory Delivery technology, currently combined with its Trudhesa migraine treatment, reportedly facilitates high absorption rates.

Catalent has announced a multi-year $350m investment at its facility in Bloomington, Indiana, to expand biologics drug substance and drug product manufacturing capabilities.

The excipients, equipment, and API companies have joined forces on Inhalation Together, an initiative aimed at advancing dry-powder inhalation solutions.

The excipients, equipment, and API companies have joined forces on Inhalation Together, an initiative aimed at advancing dry-powder inhalation solutions.

Novartis has created a new organizational structure and operating model: which it says will make the company more agile and competitive.

Memo Therapeutics AG will receive CHF 10.5m (US $11.4m) from the Swiss government to clinically develop a SARS-CoV-2 antibody against COVID-19, allowing it to start […]

Stevanato Group is showcasing its SG Alina disposable, variable-dose pen injector platform, available with customizable features, at CPhI Worldwide 2021.

Novartis, which has been a shareholder in Roche for more than 20 years, will sell its stake in the business to Roche for $20.7bn.

A report from the industry eventâs organizers indicates American companies have an edge on drug delivery innovation but lag in operational sustainability.

Nucala, a monoclonal antibody indicated for patients with chronic rhinosinusitis with nasal polyps, has been approved by the Food and Drug Administration.

Adoption of single-use technologies has grown exponentially over the last decade: but what will drive the tech forward in the coming years?

In recent years, it has become clear that RNA molecules are an emerging as a class of therapeutics of relevance to multiple diseases, most recently […]

On May 5, a panel of experienced industry experts will discuss recent developments during Innovations in Drug Delivery, a free one-hour industry webinar.

On May 5, the Innovations in Drug Delivery webinar will feature views on trends and technology from AstraZeneca, i20 Therapeutics, and top researchers.

While the field is decades old, according to one specialist, more and more industry professionals are noting its diagnostic and treatment potential.

A representative from the small-molecule solutions company explains how the ever-increasing mountain of life-sciences data has impacted drug development.

The pharma giant and the clinical-stage drug developer will join on a pilot study investigating a candidateâs potential in overcoming resistance of a cancer drug.

The two companies have joined forces to collaborate on the commercial launch of Gimoti, a nasal spray for patients suffering from diabetic gastroparesis.

A leader from the pharma solutions firm will discuss the future of drug delivery at a keynote during the CPhI Festival of Pharma virtual event.

Ena Respiratoryâs preventative nasal spray treatment could reach human trials within four months, following results from an animal study released today which showed the spray […]

Innovations in Drug Delivery Part II, a free online event on July 15, will feature novel technologies and innovative solutions to current challenges.